Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001584759-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
19,234
Total Value
$0.00
P&L
+inf% (+$558,363.02)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (right to buy) | Derivative | Feb 12, 2026 | Grant/Award | 19,234 | $0.00 | $0.00 | 19,234 | Direct | โ | View Details |